tirzepatide cause bad breath TrimRX Ozempic Teeth: How GLP-1 Medications

However, the broader regulatory direction - including the 503A legal standard requiring documented individualized clinical necessity, and the FDA's escalating enforcement posture across the compounded GLP-1 category throughout 2025 and 2026 - affects the legal environment in which all compounded GLP-1 programs operate

It is currently indicated for use in adults with obesity (with a BMI of 30 kg/m2 or greater) or overweight adults (with a BMI of 27 kg/m2 or greater) who also have weight-related medical problems such as type 2 diabetes, high blood pressure, obstructive sleep apnea, or cardiovascular disease

Initial study results show that people lose a larger percentage of weight as much as 30% of their body weight when they take retatrutide compared with placebo

In South Africa, the US drugmaker Lilly competes with Denmark's Novo Nordisk, which makes Wegovy and Ozempic and has indicated plans to expand into Africa following its South Africa launch of Wegovy

To continue you confirm that you are qualified research professional aged 21 or older

Like any medication, it can have side effects, some of which may affect the heart